Dan Roden
Faculty Member
Last active: 3/24/2020

Dan Roden M.D. - Publications

  1. Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study. Oshikoya KA, Carroll R, Aka I, Roden DM, Van Driest SL (2019) Drugs Real World Outcomes 6(2): 59-71
    › Primary publication · 30919267 (PubMed) · PMC6520321 (PubMed Central)
  2. A Decision-Theoretic Approach to Panel-Based, Preemptive Genotyping. Shi Y, Graves JA, Garbett SP, Zhou Z, Marathi R, Wang X, Harrell FE, Lasko TA, Denny JC, Roden DM, Peterson JF, Schildcrout JS (2019) MDM Policy Pract 4(2): 2381468319864337
    › Primary publication · 31453360 (PubMed) · PMC6699004 (PubMed Central)
  3. A current understanding of drug-induced QT prolongation and its implications for anticancer therapy. Roden DM (2019) Cardiovasc Res 115(5): 895-903
    › Primary publication · 30689740 (PubMed)
  4. Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics. Wells QS, Gupta DK, Smith JG, Collins SP, Storrow AB, Ferguson J, Smith ML, Pulley JM, Collier S, Wang X, Roden DM, Gerszten RE, Wang TJ (2019) J Am Coll Cardiol 73(17): 2195-2205
    › Primary publication · 31047008 (PubMed) · PMC6501811 (PubMed Central)
  5. Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors. Jerome RN, Pulley JM, Roden DM, Shirey-Rice JK, Bastarache LA, R Bernard G, B Ekstrom L, Lancaster WJ, Denny JC (2018) Drug Saf 41(3): 303-311
    › Primary publication · 29185237 (PubMed) · PMC5828879 (PubMed Central)
  6. The Influence of Big (Clinical) Data and Genomics on Precision Medicine and Drug Development. Denny JC, Van Driest SL, Wei WQ, Roden DM (2018) Clin Pharmacol Ther 103(3): 409-418
    › Primary publication · 29171014 (PubMed) · PMC5805632 (PubMed Central)
  7. Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects. Volpi S, Bult CJ, Chisholm RL, Deverka PA, Ginsburg GS, Jacob HJ, Kasapi M, McLeod HL, Roden DM, Williams MS, Green ED, Rodriguez LL, Aronson S, Cavallari LH, Denny JC, Dressler LG, Johnson JA, Klein TE, Leeder JS, Piquette-Miller M, Perera M, Rasmussen-Torvik LJ, Rehm HL, Ritchie MD, Skaar TC, Wagle N, Weinshilboum R, Weitzel KW, Wildin R, Wilson J, Manolio TA, Relling MV (2018) Clin Pharmacol Ther 103(5): 778-786
    › Primary publication · 29460415 (PubMed) · PMC5902434 (PubMed Central)
  8. Reply to Ward and Colleagues' Comment on "Using Human Experiments of Nature to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors". Jerome RN, Pulley JM, Roden DM, Shirey-Rice JK, Bastarache LA, Bernard G, Ekstrom L, Lancaster WJ, Denny JC (2018) Drug Saf 41(11): 1101
    › Primary publication · 30066313 (PubMed)
  9. Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health records. Feng Q, Wei WQ, Chung CP, Levinson RT, Sundermann AC, Mosley JD, Bastarache L, Ferguson JF, Cox NJ, Roden DM, Denny JC, Linton MF, Edwards DRV, Stein CM (2018) PLoS Med 15(8): e1002642
    › Primary publication · 30153257 (PubMed) · PMC6112635 (PubMed Central)
  10. Probing the Virtual Proteome to Identify Novel Disease Biomarkers. Mosley JD, Benson MD, Smith JG, Melander O, Ngo D, Shaffer CM, Ferguson JF, Herzig MS, McCarty CA, Chute CG, Jarvik GP, Gordon AS, Palmer MR, Crosslin DR, Larson EB, Carrell DS, Kullo IJ, Pacheco JA, Peissig PL, Brilliant MH, Kitchner TE, Linneman JG, Namjou B, Williams MS, Ritchie MD, Borthwick KM, Kiryluk K, Mentch FD, Sleiman PM, Karlson EW, Verma SS, Zhu Y, Vasan RS, Yang Q, Denny JC, Roden DM, Gerszten RE, Wang TJ (2018) Circulation 138(22): 2469-2481
    › Primary publication · 30571344 (PubMed)